Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New 10/14/08 Dutton Update is out

Just one mans opinion, but I'd rather the company not spend that 67K again on Dutton...they really do us no good and all they do is parrot what is released in the companys' PR's and RG's letters. Even with all the positive news we have had...they're still pushing that .55 target price.

If I had an option to advise the leadership of what I would do with the same expenditure (which I don't by the way)...I would strongly suggest that they start having quarterly open conference calls where invited analysts and shareholders could call in with comments and questions. Obviously certain topics cannot be leaborated upon but an open-ended conference call...4 times a year would only cost us 35k-45k , if i remmeber correctly,...to me that would be money much much better invested in our company and much more availability to get our story out to the public and private sector.....not to mention... maybe some questions many of us have had could be answered or at least expounded upon.

Just a thought, but IMO worth more than another dime spent on Dutton





JMHO

Share
New Message
Please login to post a reply